Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Treasury Stock: ¥0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603079 Zhejiang Shengda Bio-Pharm Co Ltd SHSE:603079
69 GF Score
Price ¥13.38
GF Value ¥13.99
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shengda Bio-Pharm Co Treasury Stock?

Zhejiang Shengda Bio-Pharm Co SHSE:603079 +4.53% 69 Treasury Stock is ¥0.0 Mil as of Jun. 2026. GuruFocus rates SHSE:603079 with a GF Score™ of 69/100 and a GF Value™ of ¥13.99 (Fairly Valued). The stock has 5 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Zhejiang Shengda Bio-Pharm Co's treasury stock for the quarter that ended in Jun. 2026 was ¥0.0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Zhejiang Shengda Bio-Pharm Co Treasury Stock Historical Data

* Premium members only.

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shengda Bio-Pharm Co Treasury Stock Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -8.97 -22.08 0.00

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.08 -22.08 0.00 -21.13 0.00
SHSE:603079
69GF Score
Zhejiang Shengda Bio-Pharm Co Ltd SHSE:603079
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Shengda Bio-Pharm Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of ¥0.0 Mil mean?
Zhejiang Shengda Bio-Pharm Co (SHSE:603079) has a Treasury Stock of ¥0.0 Mil as of Jun. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Zhejiang Shengda Bio-Pharm Co and its competitors.
Is Zhejiang Shengda Bio-Pharm Co's Treasury Stock too high?
Zhejiang Shengda Bio-Pharm Co's current Treasury Stock is ¥0.0 Mil. Overall, Zhejiang Shengda Bio-Pharm Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shengda Bio-Pharm Co's Treasury Stock compare to ZTS?
Zhejiang Shengda Bio-Pharm Co's Treasury Stock of ¥0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Zhejiang Shengda Bio-Pharm Co and its competitors. Zhejiang Shengda Bio-Pharm Co's current Treasury Stock is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shengda Bio-Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shengda Bio-Pharm Co (SHSE:603079) is currently considered Fairly Valued. The stock's GF Value™ is ¥13.99, compared to a current price of ¥13.38 — trading 4.4% below its estimated fair value. The current Treasury Stock is ¥0.0 Mil. Zhejiang Shengda Bio-Pharm Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Zhejiang Shengda Bio-Pharm Co (SHSE:603079), the current Treasury Stock is ¥0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shengda Bio-Pharm Co stock appears to be undervalued. The current stock price of ¥13.38 is trading 4.4% below its estimated GF Value™ of ¥13.99. GuruFocus considers Zhejiang Shengda Bio-Pharm Co to be Fairly Valued.

Key valuation signals for SHSE:603079:

  • Treasury Stock: ¥0.0 Mil
  • GF Value™: ¥13.99 vs. price of ¥13.38 (4.4% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Shengda Bio-Pharm Co Business Description

Address No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid, and other vitamin products, nisin, natamycin, and sucrose fermentation products.
69GF Score

Get the complete analysis for SHSE:603079

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥13.38
Price
¥13.99
GF Value